Research & Publications †
( † Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)
Medhat Askar, MD, PhD, is the Director of Allogen Laboratories and a Staff Physician in the Transplant Center of the Digestive Diseases Institute. He is also Associate Professor in the Department of Surgery at the Cleveland Clinic Lerner College of Medicine of Case Western Reserve University.
He is board-certified by the American Board of Histocompatibility and Immunogenetics, the American Board of Medical Laboratory Immunology, and the American Board of Bioanalysis in Diagnostic Immunology. His clinical interests include immunology, immunogenetics and transplantation.
Dr. Askar's clinical responsibilities as the Director of Allogen Laboratories in Cleveland, Ohio and Charleston, West Virginia include overseeing clinical testing performed for solid organ and stem cell transplant candidates, recipients and donors.
While his primary clinical responsibility is in the area of laboratory supervision, he also provides clinical research support for the transplant services and participates in resident and fellowship educational activities.
Medhat is very active in several roles in the Cleveland Clinic Lerner College of Medicine; including serving as a PBL Facilitator and a faculty member of the first year medical student curriculum in Immunology.He also serves as a member of the CCLCM Admissions Committee and has been the research preceptor for numerous medical students, residents and fellows.
Dr. Askar is a member of many committees within national and international professional organizations including the Education Committee of the Transplantation Society and the Quality and Standards Committee of the American Society for Histocompatibility and Immunogenetics (ASHI). He is a Commissioner of the ASHI Accreditation Review Board and the Vice Chair of the Diplomat Exam Committee of The American Board of Histocompatibility and Immunogenetics. He has authored and co-authored manuscripts in peer reviewed medical journals, a book Chapter, and serves as a reviewer for many high impact transplant journals including the American Journal of Transplantation, The Biology of Blood and Marrow Transplantation, Human Immunology, Transplant Infectious Diseases, and Transplant International.
Immunogenetics and Transplant Immunology
Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.
To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. The Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists
receive or have the right to receive royalties or (iv) its physicians/scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, the Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.
As of 4/20/2015, Dr. Askar has reported no financial relationship with industry that is applicable to this listing. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by the Cleveland Clinic. To learn more about the Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.
Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers’ discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias. * Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.